Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2695-2699

  Kalra, Paul R ^a   Morley, Chris ^b   Barnes, Susie ^c   Menown, Ian ^d   Kassianos, George ^e   Padmanabhan, Sandosh ^f   Gupta, Sandeep ^g   Lang, Chim C ^h  

^a PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^b BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c Servier Laboratories Limited   (United Kingdom)

^d Craigavon Cardiac Centre   (United Kingdom)

^e Ringmead Medical Practice   (United Kingdom)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g Whipps Cross and St Bartholomews Hospitals   (United Kingdom)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Angina; Beta blockers; Heart failure; Myocardial infarction; Persistence

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; PROPRANOLOL; SOTALOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; BRONCHOSPASM; COHORT ANALYSIS; DISEASE COURSE; DIZZINESS; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT WITHDRAWAL; VASOCONSTRICTION;

ANGINA; BETA-BLOCKERS; HEART FAILURE; MYOCARDIAL INFARCTION; PERSISTENCE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84883751721     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.116     Document Type: Article

References (32)

1. Coronary heart disease statistics Accessed at http://www.bhf.org/ publications 2010 (May 2011)
2. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
3. M. Packer, A.J. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
4. M. Lainscak, C. Moullet, N. Schön, and M. Tendera Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience Int J Cardiol 122 2 2007 149 155
5. K. Fox, J.S. Borer, and A.J. Camm Resting heart rate in cardiovascular disease JACC 50 2007 823 830
6. NICE clinical guideline 48: secondary prevention in primary and secondary care for patients following a myocardial infarction Accessed at http://guidance.nice.org.uk/CG48 2007 (May 2011)
7. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
8. K. Fox, M.A. Garcia, and D. Ardissino Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
9. R.J. Gibbons, J. Abrams, and K. Chatterjee ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina) J Am Coll Cardiol 41 2003 159 168
10. J. López-Sendón, K. Swedberg, and J. McMurray Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
11. M. Komajda, F. Follath, and K. Swedberg The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474
12. D.H. Elder, M. Pauriah, and C.C. Lang Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study? QJM 103 2010 305 310
13. G.C. Fonarow, W.T. Abraham, and N.M. Albert Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Am J Cardiol 102 2008 1524 1529
14. J. Tomcsányi, A. Wettstein, and E. Toldy-Schedel Switching beta-blocker therapy in chronic heart failure Int J Cardiol 130 2008 497 499
15. G.H. Gislason, J.N. Rasmussen, and S.Z. Abildstrom Persistent use of evidence-based pharmacotherapy in HF is associated with improved outcomes Circulation 116 2007 737 744
16. C. Opasich, A. Boccanelli, and M. Cafiero Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study Eur J Heart Fail 8 2006 649 657
17. L.K. Newby, N.M. LaPointe, and A.Y. Chen Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
18. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
19. S.H. Simpson, D.T. Eurich, and S.R. Majumdar A meta-analysis of the association between adherence to drug therapy and mortality BMJ 333 2006 15
20. GPRD facts and figures http://www.gprd.com/gprd/factsandfigures.asp (December 2010)
21. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure (update 2005) Eur Heart J 26 2005 1115 1140
22. BNF 56 September 2008 BMJ Group and Pharmaceutical Press London
23. N.F. Khan, S.E. Harrison, and P.W. Rose Validity of diagnostic coding within the General Practice Research Database: a systematic review Br J Gen Pract 60 572 2010 E128 E136
24. H. Jick, S.S. Jick, and L.E. Derby Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 302 1991 766 768
25. S. Maru, G.G. Koch, and M. Stender Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the UK primary care setting Diabetes Care 28 2005 20 26
26. P. Lechat, J.S. Hulot, and S. Escolano Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial Circulation 103 2001 1428 1433
27. National Heart Failure Audit Third report for the audit period between April 2008 and March 2009 http://www.ic.nhs.uk/webfiles/Services/NCASP/ audits%20and%20reports/NHS-National-Heart-Failure-Audit-09-INTERACTIVE.pdf (August 2011)
28. Myocardial Ischaemia National Audit Project [MINAP] ninth public report 2010 prepared on behalf of the MINAP Steering Group Accessed at http://www.rcplondon.ac.uk/clinical-standards/organisation/partnership/Pages/ MINAP-.aspx (May 2011)
29. M. Böhm, K. Swedberg, and M. Komajda Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
30. A. Hjalmarson, E.A. Gilpin, and J. Kjekshus Influence of heart rate on mortality after acute myocardial infarction Am J Cardiol 65 1990 547 553
31. F. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, and P.W. Armstrong Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
32. I. Menown Resting heart rate as cardiovascular risk factor MIMS Cardiovascular 3 2008 18 21